2021 International Conference on Biotechnology and Bioengineering (11th ICBB)

For submitted abstract, the review process will take place 5-15 days after your submission, at which point you will be notified by email whether it was selected for an oral or poster presentation. One registered participant can submit only one abstract, but can be a co-author in the abstract of another registered participant. 

Acceptance Notification: normally about 1-3 working days after submission confirmation.
Full Paper Submission Deadline: Oct. 20, 2021
Camara-Ready Deadline: Oct. 30, 2021

1. Pharmaceutical Chemistry & Natural Products Biosynthesis

2. Molecular Biology & Neurobiology

3. High Content Screening (in Chemical Biology) / High-Throughput Screening

4. Ribonucleoproteins in Biotechnology & Bioengineering

5. Advances in Plant Biotechnology

6. 3D Cultures & Organoids

7. Materials & Biomaterials, Nanobiotechnology & Nanobiomaterials

8. Bioinformatics & Biocomputing

9. Nucleic acid - protein interactions.

10. Application of biotechnology in medicine, agriculture and industry. More details please visit topics & themes

For abstracts only to be presented at the conference without formal publication, the submitted abstract can be a representative completed (published) or ongoing (unpublished) research.

For full papers to be considered for publishing in conference proceedings or journal, authors should commit that the submission to the conference is completely original and has not been previously published, nor is it before another conference for consideration (or an explanation has been provided in Comments to the Director). If redundant or duplicate publication or plagiarism is attempted or occurs authors should expect immediate editorial action to be taken including prompt rejection of the submitted manuscript. 

By submitting a manuscript to the conference proceedings, authors agree to comply with the above guidelines and ensure that their work adheres to the highest ethical standards in academic publishing.
 

2. Copyright: 

Authors retain the copyright of their work and agree to grant the conference proceedings a license to publish their work. Copyright License Agreement provided by publisher will be signed when the paper is accepted. The conference proceedings reserve the right to make necessary modifications to the manuscript, such as correcting grammatical errors, improving the clarity of the text, or formatting the manuscript to match our publication standards.
 

3. Peer-Review: 

All submitted abstracts and full papers will be sent for peer review by scientific committee and editorial board of conference. 

Manuscripts (other than those with insufficient quality or unlikely to be competitive enough that can not pass through initial quality control) are subject to a double-blind peer-review process by two or more experts in the fields. The reviewers evaluate the work based on its originality, scientific merit, methodology, results, and conclusion. A decision will be returned to authors in about 2-3 weeks. If due to special circumstance, the review process takes more time, authors will be informed by email. Possible decisions on a manuscript are: acceptance, revision (minor or major), rejection. Authors should respect the reviewer's comments and respond to them appropriately.
 

4. Publication Ethics and Publication Malpractice Statement:

We firmly believe that ethical conduct is the most essential virtual of any academic. We select full papers to be considered for publishing in conference proceedings follow the highest ethical standards. We expect all authors, editors, and reviewers to adhere to the following guidelines:
 

- Publication Ethics

  The conference proceedings adhere to the highest standards of ethical behavior in publication. Hence any act of plagiarism is a totally unacceptable academic misconduct and cannot be tolerated. We also do not accept manuscripts that contain hate speech, defamation, or any other form of unethical behavior.
 

- Authorship and Originality

  Authors must guarantee that their work is original and has not been previously published or under review elsewhere. The work should also not include any plagiarized content or data. All authors must be listed and have made significant contributions to the research.
 

- Conflict of Interest

  Authors must disclose any potential conflicts of interest that may influence the research or its interpretation. Reviewers must also declare any potential conflict of interest that may affect their impartiality in evaluating the manuscript.
 

- Publication Malpractice

  We take any form of publication malpractice seriously. If we suspect any form of unethical behavior or misconduct, we will investigate the matter thoroughly and take appropriate actions, including retracting the manuscript, informing relevant authorities, and banning authors from submitting to our conference proceedings in the future.